We are most pleased to share with you the exciting news that the Myelin Repair Foundation has established an official partnership with ENDECE Neural, LLC, a biopharmaceutical company based in Wisconsin. This is the MRF's first major partnership with a biopharmaceutical company, and has been established to help expedite a myelin repair medicine as a possible clinical trial candidate for MS patients.

ENDECE approached the MRF due to our expertise in myelin repair models and advanced in-house capabilities at our newly established Translational Medicine Center. This partnership represents just the beginning of the biopharmaceutical industry's growing interest in the MRF's Translational Medicine Platform, with more biopharma partnerships on the horizon.

You can read more about this new partnership here.